| Literature DB >> 22948188 |
H Irving1, J M Riveron, S S Ibrahim, N F Lobo, C S Wondji.
Abstract
Pyrethroid resistance in Anopheles funestus is threatening malaria control in Africa. Elucidation of underlying resistance mechanisms is crucial to improve the success of future control programs. A positional cloning approach was used to identify genes conferring resistance in the uncharacterised rp2 quantitative trait locus (QTL) previously detected in this vector using F6 advanced intercross lines (AIL). A 113 kb BAC clone spanning rp2 was identified and sequenced revealing a cluster of 15 P450 genes and one salivary protein gene (SG7-2). Contrary to A. gambiae, AfCYP6M1 is triplicated in A. funestus, while AgCYP6Z2 orthologue is absent. Five hundred and sixty-five new single nucleotide polymorphisms (SNPs) were identified for genetic mapping from rp2 P450s and other genes revealing high genetic polymorphisms with one SNP every 36 bp. A significant genotype/phenotype association was detected for rp2 P450s but not for a cluster of cuticular protein genes previously associated with resistance in A. gambiae. QTL mapping using F6 AIL confirms the rp2 QTL with an increase logarithm of odds score of 5. Multiplex gene expression profiling of 15 P450s and other genes around rp2 followed by individual validation using qRT-PCR indicated a significant overexpression in the resistant FUMOZ-R strain of the P450s AfCYP6Z1, AfCYP6Z3, AfCYP6M7 and the glutathione-s-transferase GSTe2 with respective fold change of 11.2, 6.3, 5.5 and 2.8. Polymorphisms analysis of AfCYP6Z1 and AfCYP6Z3 identified amino acid changes potentially associated with resistance further indicating that these genes are controlling the pyrethroid resistance explained by the rp2 QTL. The characterisation of this rp2 QTL significantly improves our understanding of resistance mechanisms in A. funestus.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22948188 PMCID: PMC3499844 DOI: 10.1038/hdy.2012.53
Source DB: PubMed Journal: Heredity (Edinb) ISSN: 0018-067X Impact factor: 3.821
Figure 1Schematic representation of the gene organisation in the BAC clone spanning the rp2 QTL in A. funestus. Vertical arrows indicate intergenic regions while horizontal arrows indicate the 5′—3′orientation of each gene. The triplicated copies of AfCYP6M1 gene are underlined. A full color version of this figure is available at the Heredity journal online.
Nucleotide polymorphism in A. funestus genes
|
|
| ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
| |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP4C35 | 915 | 10 | 0.63 | 4 | 600 | 4 | 4 | 4 | 3 | 1 | 1 | 7 | 8 | 0.78 | 0.36 | 0.91 | 315 | 2 | 0 | 2 | 0.37 |
| CYP4H18 | 503 | 11 | 0.89 | 7 | 333 | 1 | 1 | 0 | 0 | 2 | 1 | 1 | 2 | 0.25 | 0.63 | 0.12 | 170 | 7 | 2 | 9 | 2.1 |
| CYP6AF1 | 438 | 12 | 0.74 | 6 | 363 | 5 | 0 | 0 | 0 | 5 | 5 | 0 | 5 | 0.38 | 1.5 | 0.0 | 73 | 4 | 3 | 7 | 2.5 |
| CYP6AH1 | 901 | 25 | 1.3 | 4 | 699 | 13 | 4 | 0 | 1 | 16 | 15 | 2 | 17 | 1.15 | 4.3 | 0.2 | 203 | 4 | 4 | 8 | 2.04 |
| CYP6M1a | 700 | 13 | 0.68 | 10 | 444 | 2 | 1 | 0 | 0 | 3 | 3 | 0 | 3 | 0.24 | 1.01 | 0.0 | 254 | 4 | 6 | 10 | 1.4 |
| CYP6M1b | 911 | 27 | 1.3 | 6 | 648 | 11 | 12 | 4 | 4 | 15 | 16 | 7 | 23 | 1.5 | 4.6 | 0.59 | 263 | 3 | 1 | 4 | 0.73 |
| CYP6M1c | 804 | 39 | 1.9 | 15 | 657 | 25 | 14 | 5 | 5 | 29 | 29 | 10 | 39 | 2.01 | 7.3 | 0.6 | 145 | 3 | 1 | 4 | 1.2 |
| CYP6M3 | 522 | 17 | 1.24 | 11 | 438 | 8 | 4 | 1 | 1 | 10 | 10 | 2 | 12 | 1.03 | 3.7 | 0.24 | 81 | 2 | 4 | 6 | 2.5 |
| CYP6M4 | 814 | 37 | 2.01 | 7 | 750 | 27 | 9 | 10 | 0 | 26 | 28 | 8 | 36 | 2.02 | 7.03 | 0.67 | 62 | 0 | 1 | 1 | 0.64 |
| CYP6M8 | 799 | 25 | 1.05 | 11 | 726 | 17 | 4 | 4 | 2 | 15 | 17 | 4 | 21 | 1.04 | 3.7 | 0.22 | 73 | 2 | 2 | 4 | 1.13 |
| CYP6N1 | 866 | 40 | 1.9 | 14 | 804 | 22 | 9 | 2 | 1 | 28 | 23 | 8 | 31 | 1.6 | 5.5 | 0.44 | 59 | 5 | 4 | 9 | 5.4 |
| CYP6R1 | 809 | 26 | 1.56 | 8 | 744 | 13 | 8 | 1 | 7 | 12 | 12 | 9 | 21 | 1.4 | 2.8 | 0.89 | 59 | 2 | 3 | 5 | 4.1 |
| CYP6S1 | 829 | 33 | 1.5 | 12 | 829 | 19 | 14 | 6 | 2 | 25 | 29 | 4 | 33 | 1.5 | 5.4 | 0.27 | / | / | / | / | / |
| CYP6S2 | 905 | 29 | 1.3 | 16 | 834 | 16 | 8 | 0 | 2 | 22 | 20 | 4 | 24 | 1.13 | 4.2 | 0.19 | 70 | 3 | 2 | 5 | 2.9 |
| CYP6Y1 | 924 | 15 | 0.66 | 8 | 846 | 8 | 6 | 1 | 2 | 11 | 10 | 4 | 14 | 0.69 | 2.2 | 0.23 | 76 | 0 | 1 | 1 | 0.26 |
| CYP6Y2 | 868 | 9 | 0.46 | 5 | 868 | 6 | 3 | 1 | 1 | 7 | 7 | 2 | 9 | 0.46 | 1.5 | 0.14 | / | / | / | / | / |
| CYP6Z1 | 924 | 28 | 1.33 | 14 | 510 | 13 | 6 | 4 | 2 | 13 | 12 | 7 | 19 | 1.6 | 4.1 | 0.76 | 413 | 2 | 7 | 9 | 1.02 |
| CYP9B2 | 561 | 15 | 0.94 | 9 | 459 | 5 | 6 | 4 | 4 | 3 | 3 | 8 | 11 | 0.87 | 1.5 | 0.7 | 102 | 2 | 2 | 4 | 1.3 |
| CYP9M1 | 891 | 25 | 0.94 | 9 | 891 | 15 | 10 | 7 | 4 | 14 | 15 | 10 | 25 | 0.94 | 2.6 | 0.41 | / | / | / | / | / |
| CYP303A1 | 765 | 9 | 0.48 | 8 | 765 | 6 | 3 | 2 | 1 | 6 | 6 | 3 | 9 | 0.46 | 1.6 | 0.17 | / | / | / | / | / |
| 7980 | 649 | 17 | 0.9 | 8 | 336 | 0 | 2 | 0 | 1 | 1 | 0 | 2 | 2 | 0.19 | 0.0 | 0.26 | 311 | 6 | 9 | 15 | 1.7 |
| 9073 | 734 | 33 | 1.57 | 13 | 510 | 7 | 7 | 1 | 1 | 12 | 11 | 3 | 14 | 0.89 | 3.3 | 0.23 | 224 | 15 | 4 | 19 | 3.1 |
| 9624 | 788 | 24 | 1.04 | 10 | 786 | 13 | 11 | 6 | 2 | 16 | 17 | 7 | 24 | 1.04 | 3.5 | 0.28 | / | / | / | / | / |
| CPLC5 | 390 | 3 | 0.17 | 4 | 390 | 2 | 1 | 0 | 0 | 3 | 3 | 0 | 3 | 0.17 | 0.6 | 0.0 | / | / | / | / | / |
| CPLC8 | 253 | 8 | 1.14 | 9 | 253 | 3 | 6 | 2 | 2 | 5 | 3 | 6 | 9 | 1.14 | 3.2 | 0.34 | |||||
| CPLC9 | 317 | 17 | 2.05 | 7 | 117 | 3 | 2 | 0 | 0 | 5 | 5 | 0 | 5 | 1.4 | 5.5 | 0.0 | 200 | 6 | 6 | 12 | 2.4 |
| CPR* | 895 | 5 | 0.18 | 4 | 792 | 3 | 2 | 1 | 1 | 3 | 4 | 1 | 5 | 0.21 | 0.75 | 0.03 | 101 | 0 | 0 | 0 | 0 |
| GSTe2 | 756 | 13 | 0.54 | 13 | 612 | 4 | 4 | 2 | 3 | 3 | 3 | 5 | 8 | 0.36 | 0.7 | 0.25 | 143 | 1 | 4 | 5 | 1.13 |
| Total | 20431 | 565 | 17004 | 271 | 161 | 68 | 52 | 311 | 308 | 124 | 432 | 3397 | 73 | 66 | 139 | ||||||
| Average | 1.05 | 8.7 | 0.91 | 2.86 | 0.31 | 1.31 | |||||||||||||||
L, length of the nucleotide sequence; S, number of mutations; π, average number of nucleotide substitution per site; h, number of haplotypes; Lc, Length of coding region; Ts, transitions; Tv, transversions Syn, synonymous substitutions; Rep, replacement substitutions; Σ, total; πc, nucleotide diversity in coding region; Ks, per synonymous site; Ka, per non-synonymous site; πnc, nucleotide diversity in non-coding region. * CPR, cytochrome P450 reductase
Figure 2Plot of mortality as a function of alleles inherited from susceptible parents at loci associated with resistance in rp2 QTL using F6 generation for Family 1 (a) (FUMOZ-R ♂ X FANG ♀) and (b) for Family 10 (FUMOZ-R ♀ X FANG ♂).
Figure 3Plot of logarithm of odd scores for the pyrethroid resistance rp2 QTL in Family 1 using F6 progeny. The y axis indicates logarithm of odd ratio scores, and the x axis indicates chromosome positions. Solid lines represent logarithm of odd estimated by composite-interval mapping and dashed lines represent logarithm of odd estimated by interval mapping. The straight line along the top of the graph represents the threshold value for logarithm of odd as determined by permutations. Names of markers are listed around QTL locations.
Multiple-interval mapping estimates of QTL position and associated genetic, environmental, phenotypic, additive and dominance effects associated with pyrethroid resistance in Family 1 A. funestus using F6 progeny
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|
| 22.16 (88.7%) | 2.84 (11.3%) | 25 | CYP6P9 |
| 13.7 (7.3–14.3) | A, −4.77 | 65.8 |
| D, 4.02 | 19.6 | ||||||
| CYP6M4 |
| 65.9 (60.5–69.5) | A, −0.76 | 4.1 | |||
| D, 0.45 | −0.8 | ||||||
| BU92 |
| 92 (85.9–100.9) | A, −0.10 | 0.2 | |||
| D, 0.31 | −0.3 |
σg2, σp2, σe2, respectively, for genetic, phenotypic (in parentheses) and environmental variance; A for additive; D for dominance; confidence intervals for QTL position are in parentheses near the position estimate.
Figure 4Gene expression profiling of candidate genes: a is the expression profile of some of the 28 tested P450 genes in females of the resistant strain FUMOZ-R and the susceptible strain FANG using the Beckman GeXP multiplex method. The normalised expression ratio of each gene against the RSP7 gene is represented on the primary vertical axis, while the secondary vertical axis (curve) represents the fold change of each gene between FUMOZ-R and FANG. Significant differential expressions are indicated by asterisks: ** for P<0.01 and * if P<0.05. b is the qRT–PCR expression patterns of the four candidate genes in females of the resistant strain FUMOZ-R and the susceptible strain FANG. The normalised (2−ΔΔCt) relative expression ratio of each gene against the RSP7 and Actin genes is represented on the primary vertical axis while the secondary vertical axis (curve) represents the fold change of the 2−ΔΔCt of each gene between FUMOZ-R and FANG.
Summary statistics for polymorphism of AfCYP6Z1 and AfCYP6Z3 between the FANG susceptible and FUMOZ-R resistant strains
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
| |||||||
| FANG-S | 4 | 32 | 19 | 13 | 0.0114 (16.8) | −0.37 ns | −0.27ns |
| FUMOZ-R | 4 | 28 | 18 | 10 | 0.0094 (14.0) | −0.86 ns | −0.86ns |
| Total | 8 | 49 | 30 | 19 | 0.0115 (17.1) | −0.52 ns | −0.56ns |
|
| |||||||
| FANG-S | 5 | 39 | 33 | 6 | 0.0116 (17.2) | −0.61 ns | −0.61ns |
| FUMOZ-R | 6 | 34 | 29 | 5 | 0.0117 (17.3) | 1.04ns | 1.34ns |
| Total | 11 | 59 | 50 | 9 | 0.015 (22.7) | 0.61ns | 0.38ns |
N, number of sequences (n); Nonsyn, Non-synonymous mutations; ns, not significant; S, number of polymorphic sites; Syn, Synonymous mutations; Tajima's D and Fu and Li's D statistics; π, nucleotide diversity (k=mean number of nucleotide differences).
Figure 5Schematic representation of haplotypes of AfCYP6Z3 and AfCYP6Z1 genes between the susceptible FANG and the resistant FUMOZ-R strains. a, b show the nucleotide polymorphic sites for both AfCYP6Z3 and AfCYP6Z1, respectively, while (c, d) are for the amino acid polymorphism. Below the list of sequences, R or S indicates the positions that are polymorphic in the resistant or susceptible mosquitoes, respectively, while an asterisk (*) marks a position polymorphic in both phenotypes. (e) Neighbour-joining tree of AfCYP6Z3 showing the clades specific to each phenotype while (f) is for AfCYP6Z1.